课题基金 / 基金详情

MOLECULAR CHARACTERIZATION--HISTAMINE RECEPTOR SUBTYPES

MOLECULAR CHARACTERIZATION--HISTAMINE RECEPTOR SUBTYPES
分子表征——组胺受体亚型
批准号:
2422246
负责人:
LOYD H BURGESS
金额:
$9.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-01 至 1999-01-30

项目摘要

项目成果

LOYD H BURGESS的其他基金

相似基金

相关文献

中文摘要
翻译
长期目标是克隆新的人组胺受体
英文摘要
The long-term objectives are to clone novel human histamine receptor subtypes, to aid in the development of novel histamine H3 receptor agonists and antagonists to treat CNS diseases. The Specific Aims of this grant are to: (1) utilize the polymerase chain reaction (PCR) with degenerate primers, to amplify cDNAs made from human H3 receptor expressing tissues (e.g., caudate) or cells (e.g., U373MG astrocytoma), to clone the H3 receptor cDNA; (2) expression screen a GPCR-enriched cDNA library derived from human H3 receptor expressing tissues or cells, by using a selective high affinity H3 receptor antagonist (e.g., 125I-IPP or 125I-GT-2232); (3) create a stable cell line expressing the human H3 receptor clone. (4) utilize this H3 receptor clone to search for additional subtypes via degenerate primer PCR or low stringency hybridization. The first two aims use modifications of two proven strategies to isolate cDNA clones expressing the human histamine H3 receptor. The subsequent aims are designed to utilize this cloned receptor in the further development of H3 receptor antagonists and agonists. This grant would assist in development of novel therapeutic approaches to many debilitating CNS disorders (i.e., sleep disorders, anxiety, Alzheimer's disease and attention deficit hyperactive disorder. PROPOSED COMMERCIAL APPLICATION: Research will be conducted towards isolating and characterizing a cDNA clone encoding the H3 receptor, by degenerate primer PCR and expression screening.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANTICANCER MECHANISMS OF LYCOPENE ACTION
  • 批准号:
    8360049
  • 项目类别:
  • 资助金额:
    $12.0万
  • 财政年份:
    2011
  • 负责人:
    LOYD H BURGESS
  • 依托单位:
ANTICANCER MECHANISMS OF LYCOPENE ACTION
  • 批准号:
    8167911
  • 项目类别:
  • 资助金额:
    $12.09万
  • 财政年份:
    2010
  • 负责人:
    LOYD H BURGESS
  • 依托单位:
ANTICANCER MECHANISMS OF LYCOPENE ACTION
  • 批准号:
    7960198
  • 项目类别:
  • 资助金额:
    $9.66万
  • 财政年份:
    2009
  • 负责人:
    LOYD H BURGESS
  • 依托单位:
ANTICANCER MECHANISMS OF LYCOPENE ACTION
  • 批准号:
    7725120
  • 项目类别:
  • 资助金额:
    $9.04万
  • 财政年份:
    2008
  • 负责人:
    LOYD H BURGESS
  • 依托单位:
海外基金